MNK looking to sell its generics business to focus on specialised treatments.
MNK is trying to move in the right direction, instead of following the so-far disastrous decision that Teva took to double down on its generics business.
Teva shares plummet 21%, page-7
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.28 |
Change
0.000(0.00%) |
Mkt cap ! $1.478B | |||
| Open | High | Low | Value | Volume |
| $1.29 | $1.31 | $1.27 | $969.2K | 753.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 12283 | $1.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.28 | 29239 | 11 |
View Market Depth
| Last trade - 13.03pm 05/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |